Literature DB >> 6311952

P85gag-mos encoded by ts110 Moloney murine sarcoma virus: rapid at the restrictive temperature.

L H Stanker, G E Gallick, J P Horn, R B Arlinghaus.   

Abstract

The stability of P85gag-mos, encoded by ts110 Moloney murine sarcoma virus, was studied. P85gag-mos was found to turn over more rapidly at 39 degrees C than 33 degrees C in two different cell lines. One of these is a non-producer cell clone (6m2) which appears only to express P85 at 33 degrees C. The other cell line (206-2IC) produces P85gag-mos at both 33 degrees C and 39 degrees C, although in lower amounts at the higher temperature. Both cell lines exhibit the normal morphological phenotype following a shift to the restrictive temperature. These data suggest that the presence of P85gag-mos alone is insufficient to cause transformation, and that some function(s) associated with the molecule may be heat-labile.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311952     DOI: 10.1099/0022-1317-64-10-2203

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Reversion of thermosensitive splicing defect of Moloney murine sarcoma virus ts110 by oversplicing of viral RNA.

Authors:  R Hamelin; N Honore; D Sergiescu; B Singh; J Gerfaux; R B Arlinghaus
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

2.  Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells.

Authors:  R Hamelin; B L Brizzard; M A Nash; E C Murphy; R B Arlinghaus
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Temperature-sensitive splicing defect of ts110 Moloney murine sarcoma virus is virus encoded.

Authors:  R Hamelin; K Kabat; D Blair; R B Arlinghaus
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  Expression of the v-mos gene alters a Mr 55,000 protein during acute infection by Moloney murine sarcoma virus.

Authors:  B Singh; J T Sparrow; A M Hedge; R B Arlinghaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.